Related Experiment Video
Updated: Jun 23, 2026

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy
E Laane1, K Pokrovskaja Tamm, E Buentke
1Department of Oncology and Pathology, Cancer Centre Karolinska R8:03, Karolinska Institutet and Karolinska University Hospital, Stockholm S-171 76, Sweden.
Abstract:
Glucocorticoids are fundamental drugs used in the treatment of lymphoid malignancies with apoptotic cell death as the hitherto proposed mechanism of action. Recent studies, however, showed that an alternative mode of cell death, autophagy, is involved in the response to anticancer drugs. The specific role of autophagy and its relationship to apoptosis remains, nevertheless, controversial: it can either lead to cell survival or can function in cell death. We show that dexamethasone induced autophagy upstream of apoptosis in acute lymphoblastic leukemia cells. Inhibition of autophagy by siRNA-mediated repression of Beclin 1 expression inhibited apoptosis showing an important role of autophagy in dexamethasone-induced cell death. Dexamethasone treatment caused an upregulation of promyelocytic leukemia protein, PML, its complex formation with protein kinase B or Akt and a PML-dependent Akt dephosphorylation. Initiation of autophagy and the onset of apoptosis were both dependent on these events. PML knockout thymocytes were resistant to dexamethasone-induced death and upregulation of PML correlated with the ability of dexamethasone to kill primary leukemic cells. Our data reveal key mechanisms of dexamethasone-induced cell death that may inform the development of improved treatment protocols for lymphoid malignancies.
Insights
Dexamethasone induces autophagy before apoptosis in acute lymphoblastic leukemia cells. Autophagy inhibition blocks cell death, revealing its crucial role in glucocorticoid cancer therapy.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Glucocorticoids are standard treatments for lymphoid malignancies, primarily acting via apoptosis.
- Autophagy, a cell death pathway, is increasingly recognized in anticancer drug responses, but its role alongside apoptosis is debated.
- The precise interplay between autophagy and apoptosis in glucocorticoid treatment requires elucidation.
Purpose of the Study:
- To investigate the role and mechanism of autophagy in dexamethasone-induced cell death in acute lymphoblastic leukemia (ALL).
- To determine the relationship between autophagy, apoptosis, and the promyelocytic leukemia protein (PML) pathway in ALL.
- To identify potential therapeutic targets for enhancing glucocorticoid efficacy in lymphoid malignancies.
Main Methods:
- Utilized siRNA to inhibit Beclin 1 expression, a key autophagy regulator.
- Examined dexamethasone-induced changes in autophagy and apoptosis markers in ALL cells.
- Investigated the interaction between PML, Akt (protein kinase B), and their dephosphorylation status.
- Assessed dexamethasone sensitivity in PML knockout thymocytes.
Main Results:
- Dexamethasone treatment initiated autophagy preceding apoptosis in ALL cells.
- Inhibition of autophagy via Beclin 1 knockdown abrogated dexamethasone-induced apoptosis.
- Dexamethasone upregulated PML, leading to PML-Akt complex formation and Akt dephosphorylation, which were essential for both autophagy and apoptosis.
- PML-deficient cells exhibited resistance to dexamethasone, and increased PML levels correlated with drug-induced cell death.
Conclusions:
- Autophagy plays a critical, pro-death role upstream of apoptosis in dexamethasone-treated ALL cells.
- The PML-Akt signaling axis is a key mediator of dexamethasone-induced autophagy and apoptosis.
- Targeting the PML pathway and modulating autophagy may offer novel strategies for improving lymphoid malignancy treatment.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
